| Popis: |
Today, the parasitic diseases are the most common in the world and occupy one of the first places in terms of prevalence and economic losses. The reasons for this situation, according to experts, are low-quality epidemiologically dangerous water and low compliance with sanitary and hygienic standards. The problem of prevention and treatment remains relevant for almost all countries, including Ukraine. Objective - to conduct a marketing analysis of the range of the domestic pharmaceutical market of antiparasitic drugs. Material and methods. A marketing analysis was conducted using structural, logical, graphical, systematic and content analysis of data from the State Register of Drugs. Results. The first stage of the research was to study the range of antiparasitic drugs represented on the pharmaceutical market of Ukraine. It has been determined that in the pharmaceutical market, according to the State Register of Drugs of Ukraine, 22 names of anthelmintic drugs are registered. It has been established that the drugs, supplied to the domestic pharmaceutical market from every corner of the world, are 12 trade names, among which the leading positions in terms of supply are India and France (23% respectively). Antiparasitic drugs are presented in 3 dosage forms, among which the largest share are tablets - 65.2%, oral suspensions - 30.4%, the least in the pharmaceutical market are phytodrugs with antihelmintic activity (4.6%). The analysis of the registered antihelmintic drugs has shown that 95.6% of the study drugs are available by prescription. Conclusions. It has been found that the largest share of drugs are benzimidazole derivatives, which account for 47.8% of the total range of the studied drugs, the most common among anthelmintic drugs are dosage forms in tablets (65.2%). |
